Enchancers for the transdermal flux of nivadipine

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

514946, 514947, 424449, A61K 3100, A61K 3144, A61F 1300

Patent

active

050011391

ABSTRACT:
The transdermal flux rates of 1,4-dihydropyridine derivatives, such as nilvapidine and its enantiomers may be increased by the use of a solvent vehicle which comprises dioctyl adipate, isopropyl myristate, benzyl alcohol, diisopropyl adipate, a mixture of 5 to 50% ethyl alcohol and 95-50% of diisopropyl adipate, or a mixture of any of the foregoing.

REFERENCES:
patent: 4284634 (1981-08-01), Satu
patent: 4338322 (1982-07-01), Satu
patent: 4537898 (1985-08-01), Hoff et al.
patent: 4685911 (1987-08-01), Konno et al.
Patent Abstracts of JP-vol. 10, No. 166 (C-353) (2222), 13th Jun. 1986; and JP-A- 61 18717 (Nichiban).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Enchancers for the transdermal flux of nivadipine does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Enchancers for the transdermal flux of nivadipine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Enchancers for the transdermal flux of nivadipine will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2010301

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.